Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 2 · 33.3%Very low 2 · 33.3%Low 0 · 0%Moderate 2 · 33.3%High 0 · 0%

Naftopidil vs Eviprostat (phytotherapy)

Urological symptom scores

1 finding from 1 review

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Moderate

Naftopidil vs Eviprostat (phytotherapy)

Quality of life

1 finding from 1 review

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Moderate

Naftopidil vs Eviprostat (phytotherapy)

Treatment withdrawal

It is very uncertain whether naftopidil changes treatment withdrawals for any reason compared with eviprostat (phytotherapy) (very low certainty).

1 finding from 1 review

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Very low

Naftopidil vs Eviprostat (phytotherapy)

Withdrawals due to adverse events

It is very uncertain whether naftopidil changes treatment withdrawals due to adverse events compared with eviprostat (phytotherapy) (very low certainty).

1 finding from 1 review

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Very low

Naftopidil vs Eviprostat (phytotherapy)

Cardiovascular adverse events

1 finding from 1 review

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
GRADE not reported

Naftopidil vs Eviprostat (phytotherapy)

Sexual adverse events

1 finding from 1 review

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia 2018 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
GRADE not reported